STAT Plus: AI has arrived in medical imaging. Now the FDA needs to monitor its impact on patients
BETHESDA, Md. — This is the moment of truth for the FDA’s regulation of artificial intelligence (AI) in medicine.
That was the unmistakable theme of a two-day meeting here this week that focused on how the agency will keep tabs on the safety and effectiveness of new medical imaging devices that use AI to automate tasks performed by radiologists.
